Delivery Order SPE2DR25D3015-SPE2DR26F4FZ4
- Not listed
- The Defense Logistics Agency awarded a $6,949.42 delivery order to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) on October 24, 2025, with an ultimate completion date of October 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price terms and is classified as a delivery order, indicating it is issued against a larger indefinite delivery vehicle. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $3,780.92 to AmerisourceBergen Drug Corp for the supply of Losartan-HCL 100-12.5 mg tablets (90-count) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,850.96 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $6,361.13 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets in a quantity of 90 units. This competitive award, issued on October 29, 2025, with an ultimate completion date of October 30, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,560.68 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count units) on October 31, 2025, with an ultimate completion date of November 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Losartan-HCL 100-12.5 mg tablets (90-count) with a ceiling value of $4,915.61. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The order is scheduled for completion by October 31, 2025, and will be fulfilled from the...
- The Defense Logistics Agency awarded a delivery order valued at $1,008.72 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-25 mg tablets (90-count) on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,138.05 to AmerisourceBergen Drug Corp for the supply of Losartan-HCZ 100-12.5 mg tablets in a 90-day supply. This competitively awarded, firm fixed-price delivery order was issued on November 12, 2025, with an ultimate completion date of November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $2,929.68 to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Losartan-HCTZ 100-25 mg tablets in a 90-day supply. This competitive, firm fixed-price delivery order is scheduled for completion by December 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under the company's larger Indefinite Delivery Contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $90,801.69 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count bottles) on December 30, 2025, with a completion date of December 31, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement within...
- SPE2DR25D3015Indefinite Delivery Contract
- SPE2DR25D3015-SPE2DR26F4FZ4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,461.85 to AmerisourceBergen Drug Corp for the supply of Losartan-HCL 100-12.5 mg tablets (90-count) on January 5, 2026, with completion scheduled for January 6, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single delivery of this antihypertensive medication to support federal healthcare procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, AmerisourceBergen Drug Corp leverages this comprehensive global pharmaceutical support vehicle to deliver a broad range of generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 1/4/26 |